Breast cancer Posts - Page 34 of 80 on Medivizor
Navigation Menu

Breast cancer Posts on Medivizor

Addition of traustuzumab to adjuvant anthracycline and taxane based chemotherapy does not worsen long-term heart function or health related quality of life.

Addition of traustuzumab to adjuvant anthracycline and taxane based chemotherapy does not worsen long-term heart function or health related quality of life.

Posted by on Dec 9, 2017 in Breast cancer | 0 comments

In a nutshell This study set out to evaluate heart function in patients who received traustuzumab with anthracycline and taxane–based chemotherapy. This study concluded that, in patients without heart disease at baseline, adding traustuzumab to adjuvant anthracycline and taxane–based...

Read More

Searching for stage I-III breast cancer patients to test omega-3 supplementation

Posted by on Dec 6, 2017 in Breast cancer | 0 comments

In a nutshell This trial aims to evaluate the use of omega-3 fatty acid supplements to prevent side effects caused by aromatase inhibitors. Aromatase inhibitors can cause arthralgia (bone and joint pain). The main outcomes to be investigated are the change in pain score and the change in joint symptoms. This trial is taking place in Cleveland and...

Read More

Does Alcohol Increase Cancer Risk?

Does Alcohol Increase Cancer Risk?

Posted by on Nov 15, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer |

In July 2017, the American Society of Clinical Oncology (ASCO) conducted the National Cancer Opinion Survey to find out what people in the US know about cancer.  ASCO released the results in October.  The findings have already influenced recommendations made by the organization. Beliefs About Cancer Risk Among other questions, the survey asked  4,016...

Read More

New Studies Linking Gut Bacteria and Cancer Treatment

New Studies Linking Gut Bacteria and Cancer Treatment

Posted by on Nov 8, 2017 in Blog, Breast cancer, Colorectal cancer, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 3 comments

In It’s All In Your Gut, A High Fiber Diet and the Immune System, we introduced the microbiome that lives in our body.  It helps with our digestion and makes the short-chained fatty acids (SCFAs) that are important to our immune system.  Now several recent studies are looking at bacteria in the bodies of people with cancer.   Specifically, these...

Read More

Searching for breast cancer patients with brain metastases to test a new chemotherapy drug

Posted by on Oct 30, 2017 in Breast cancer | 0 comments

In a nutshell This phase 3 trial aims to compare an investigational drug to standard chemotherapy in breast cancer patients with brain metastases. The main outcome to be investigated is overall survival (time from treatment until death from any cause). Another outcome to be measured is progression free survival (time from treatment until disease...

Read More

Searching for younger breast cancer survivors to test behavioral techniques for improved quality of life

Posted by on Oct 30, 2017 in Breast cancer | 0 comments

In a nutshell This phase 3 trial aims to evaluate the effectiveness of mindfulness meditation or survivorship education in improving behavioral symptoms in younger stage 0-III breast cancer survivors. The main outcome to be investigated is the change in depressive symptoms. This trial is taking place in the states of California, Maryland and...

Read More

Searching for patients with HER2 negative breast cancer to test whether aspirin can prevent cancer recurrence

Posted by on Oct 30, 2017 in Breast cancer | 0 comments

In a nutshell This phase 3 trial aims to evaluate how well aspirin can work to prevent recurrence of breast cancer.  The main outcome to be investigated is invasive disease free survival. Other outcomes include overall survival (time from treatment until death from any cause) and the incidence of heart disease. This trial is taking place in 985...

Read More

Searching for triple negative breast cancer patients to test the effectiveness of pembrolizumab

Posted by on Oct 30, 2017 in Breast cancer | 0 comments

In a nutshell This phase 3 trial aims to evaluate how effective pembrolizumab (Keytruda) is at treating triple negative breast cancer. The main outcome to be investigated is the invasive disease free survival. Other outcomes include the overall survival (time from treatment until death from any cause) and side effects. This trial is taking place...

Read More

Searching for patients with HER2 positive metastatic breast cancer to test palbociclib in combination with standard therapy.

Posted by on Oct 30, 2017 in Breast cancer | 0 comments

In a nutshell This phase 3 trial aims to evaluate the effectiveness of palbociclib (Ibrance) in combination with standard treatments for HER2 positive breast cancer. The main outcome to be investigated is progression free survival. This trial is taking place in Alabama, Illinois, Iowa, Nebraska and Oklahoma in the United States.  The details...

Read More